Active Ingredient: Ciprofloxacin
Caro-Paton T, et al. Is metronidazole teratogenic?
A meta-analysis. Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR Morb. Cotch MF, et al.
Trichomonas vaginalis associated with low birth weight and preterm delivery. Pharmacokinetics of intravaginal metronidazole gel. Czeizel AE, Rockenbauer M.
A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Teratology —192 14. Genotoxicity and carcinogenicity of metronidazole. Greenberg F. Possible metronidazole teratogenicity and clefting.
Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.
Kigozi GG, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda.
Klebanoff MA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.